Home › Compare › YMZBY vs ABBV
YMZBY yields 2.10% · ABBV yields 3.06%● Live data
📍 YMZBY pulled ahead of the other in Year 4
Combined, YMZBY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YMZBY + ABBV for your $10,000?
Yamazaki Baking Co., Ltd., through its subsidiaries, manufactures and sells baked goods in Japan. Its products include loaf bread, sweet buns, donuts, hard rolls, and Danish pastries; Japanese, Western style, and rice-derived and based confectionery; processed bread and noodles, prepared rice, and side dishes; and chocolates, candies, stevia-based and other sweeteners, snack foods, and soup and soup stocks, as well as jams, marmalades, jelly and yokan products, and ready-to-eat curries in retort pouches. The company also manufactures biscuits, cookies, crackers, and frozen bread dough; provides coffee and juice under the Yamazaki brand; creams, curry fillings, stuffing for Chinese filled buns, croquettes, meat patties, and mayonnaise products; and prepared mixes for bread, tempura, and fried chicken, as well as sells products procured from other companies. In addition, it is involved in the manufacture and sale of cleaning and disinfecting agents for food production equipment; operation of bread and pastry shops, restaurants, convenience stores, and supermarkets; provision of retail bakery and cafe management, in-store bakery management, general truck transport and freight forwarding, and insurance services; and design of equipment for manufacturing bread and confectionery, installation of production facilities, and other services. Further, the company offers logistics management services; and manufactures and sells stevia-based and other sweeteners. As of December 31, 2021, it operated 1,389 stores. Yamazaki Baking Co., Ltd. was incorporated in 1948 and is headquartered in Tokyo, Japan.
Full YMZBY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.